CytoMed Therapeutics Limited

📍 Singapore, Singapore🗓 Founded 2018👥 19 employees💰 Last funded Feb 2023
Biotechnology Research🌐 w2.cytomed.sg
Website LinkedIn
Incorporated in 2018, CytoMed was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore’s national research and development agency in the public sector. CytoMed is a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of novel technologies has been inspired by the clinical success of existing CAR-T in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into treatment of solid tumors.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Japan
1
Frequently asked questions
Who invested in CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited has 2 investors on record on gritt.io, 2 mid-stage.
When did CytoMed Therapeutics Limited last raise funding?
The most recent investment in CytoMed Therapeutics Limited recorded on gritt.io was in February 2023.
When was CytoMed Therapeutics Limited founded?
CytoMed Therapeutics Limited was founded in 2018.
What industry is CytoMed Therapeutics Limited in?
CytoMed Therapeutics Limited operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is CytoMed Therapeutics Limited based?
CytoMed Therapeutics Limited is headquartered in Singapore, Singapore.